HomePharma

Pharma

Off the Wire

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

BCNewswire Staff -
The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...
Off the Wire

Alpelisib Linked to Higher Diabetic Ketoacidosis Risk in Breast Cancer Patients

Angela Wood -
Alpelisib, a drug used with another medication called fulvestrant to treat a specific type of advanced breast cancer targets a part of the cancer...
Off the Wire

Kintara Therapeutics Initiates Trial for Breast Cancer Treatment with REM-001

Angela Wood -
Kintara Therapeutics has started a clinical trial to study REM-001, targeting patients with cutaneous metastatic breast cancer (CMBC). This trial, which is open to...
Features

Decade-Long Triumph: Paclitaxel and Trastuzumab in Small HER2-Positive Breast Cancer

BCNewswire Staff -
Over a notable duration of nearly 11 years, a study just published in The Lancet, confirms that the combination therapy of adjuvant paclitaxel and...
Off the Wire

Enobosarm Research Shows Promise in Advanced Breast Cancer Cases

BCNewswire Staff -
A new multi-institutional study, led by a team of researchers including Prof Carlo Palmieri, Prof Hannah Linden, and others, investigated the effectiveness and safety...
123Page 2 of 3

Hot Topics

Load more

©BCnewswire. All rights reserved. Information found here is for background research. Consult your doctor for more.

Must Read

Popular Articles